Recipharm
Recipharm is a contract development and manufacturing organisation (CDMO).
Share price
€22.56
Company register number
556498-8425
Recent deals
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Grant | |
| Total Funding | 000k | ||
| SEK | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | 25 % | 18 % | 19 % | 17 % | 49 % | 5 % | 5 % |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 16 % | 14 % | 16 % | 15 % | 16 % | 19 % | 19 % |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | (3 %) | 2 % | 5 % | 3 % | 5 % | 6 % |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit
Investments by Recipharm
Edit
ACQUISITION by Recipharm Feb 2022
ACQUISITION by Recipharm Nov 2014
ACQUISITION by Recipharm Feb 2016
ACQUISITION by Recipharm Aug 2014
ACQUISITION by Recipharm Feb 2022
ACQUISITION by Recipharm Apr 2016
ACQUISITION by Synokem Pharmaceuticals Dec 2023
ACQUISITION by Recipharm Feb 2022
